ELV vs UNH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ELV · Elevance Health$425.62 ▼ 1.48%
UNH · UnitedHealth$394.15 ▼ 0.40%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ELV +42.9%
- UNH +25.1%
Head to head
| Metric | ELV | UNH |
|---|---|---|
| Price | $425.62 | $394.15 |
| Change today | ▼ 1.48% | ▼ 0.40% |
| Market cap | $91.96B | $353.17B |
| Return, 3 months | +7.5% | -3.6% |
| Return, year to date | +23.2% | +21.0% |
| Return, 1 year | +36.6% | +24.0% |
| P/E (TTM) | 18.1 | 22.5 |
| P/B | 2.1 | 3.6 |
| P/E percentile vs own 5y | 55th | 40th |
| Dividend yield | 1.61% | 2.30% |
| Revenue growth (YoY, latest qtr) | +1.4% | -0.4% |
| Net profit growth (YoY) | +13.1% | +69.1% |
| Gross margin | – | 19.8% |
| Operating margin | – | 5.3% |
| Net margin | 2.5% | 3.5% |
| Return on equity | 11.6% | 15.9% |
| Analyst target vs. price | +14.2% | +22.5% |
| Analyst buy share | 69% | 82% |
| RSI (14) | 53 | 46 |
| 30-day volatility | 27.4% | 27.8% |
| Max drawdown, 1 year | -26.5% | -28.6% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UNH is the largest of the group by market value.
- ELV has returned the most over the past year.
- ELV carries the lowest trailing P/E.
- UNH pays the highest dividend yield.
- ELV is growing revenue fastest.
- UNH keeps the most profit per dollar of sales.
- ELV has been the calmest stock over the last 30 days.